GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Coloplast A/S (OTCPK:CLPBY) » Definitions » Price-to-Owner-Earnings

Coloplast A/S (Coloplast A/S) Price-to-Owner-Earnings : 42.96 (As of Apr. 28, 2024)


View and export this data going back to 2010. Start your Free Trial

What is Coloplast A/S Price-to-Owner-Earnings?

As of today (2024-04-28), Coloplast A/S's share price is $12.458. Coloplast A/S's Owner Earnings per Share (TTM) ended in Dec. 2023 was $0.29. It's Price-to-Owner-Earnings for today is 42.96.


The historical rank and industry rank for Coloplast A/S's Price-to-Owner-Earnings or its related term are showing as below:

CLPBY' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 21.6   Med: 45.69   Max: 86.35
Current: 42.96

During the past 13 years, the highest Price-to-Owner-Earnings of Coloplast A/S was 86.35. The lowest was 21.60. And the median was 45.69.


CLPBY's Price-to-Owner-Earnings is ranked worse than
64.77% of 281 companies
in the Medical Devices & Instruments industry
Industry Median: 32.72 vs CLPBY: 42.96

As of today (2024-04-28), Coloplast A/S's share price is $12.458. Coloplast A/S's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $0.32. Therefore, Coloplast A/S's PE Ratio for today is 38.69.

As of today (2024-04-28), Coloplast A/S's share price is $12.458. Coloplast A/S's EPS without NRI for the trailing twelve months (TTM) ended in was $0.33. Therefore, Coloplast A/S's PE Ratio without NRI for today is 38.10.

During the past 13 years, Coloplast A/S's highest PE Ratio without NRI was 54.83. The lowest was 24.17. And the median was 34.76.


Coloplast A/S Price-to-Owner-Earnings Historical Data

The historical data trend for Coloplast A/S's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coloplast A/S Price-to-Owner-Earnings Chart

Coloplast A/S Annual Data
Trend Sep14 Sep15 Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 48.16 52.53 46.03 42.48 44.04

Coloplast A/S Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.86 50.39 48.27 44.04 38.43

Competitive Comparison of Coloplast A/S's Price-to-Owner-Earnings

For the Medical Instruments & Supplies subindustry, Coloplast A/S's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Coloplast A/S's Price-to-Owner-Earnings Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Coloplast A/S's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Coloplast A/S's Price-to-Owner-Earnings falls into.



Coloplast A/S Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Coloplast A/S's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=12.458/0.29
=42.96

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Coloplast A/S  (OTCPK:CLPBY) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Coloplast A/S Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Coloplast A/S's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Coloplast A/S (Coloplast A/S) Business Description

Address
Holtedam 1-3, Humlebaek, DNK, DK-3050
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, paste, powder, seals, and intermittent catheters for continence care. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.

Coloplast A/S (Coloplast A/S) Headlines

From GuruFocus

Coloplast A/S's Dividend Analysis

By GuruFocus Research 12-07-2023